
### [MONDO:0015618](http://purl.obolibrary.org/obo/MONDO_0015618)
**Label:** genetic pancreatic disease

**Subclasses:** [MONDO:0015278](http://purl.obolibrary.org/obo/MONDO_0015278) (familial pancreatic carcinoma), [MONDO:0014554](http://purl.obolibrary.org/obo/MONDO_0014554) (infantile multisystem neurologic-endocrine-pancreatic disease), [MONDO:0017712](http://purl.obolibrary.org/obo/MONDO_0017712) (combined pancreatic lipase-colipase deficiency), [MONDO:0013685](http://purl.obolibrary.org/obo/MONDO_0013685) (pancreatic cancer, susceptibility to, 4), [MONDO:0008185](http://purl.obolibrary.org/obo/MONDO_0008185) (hereditary chronic pancreatitis), [MONDO:0017711](http://purl.obolibrary.org/obo/MONDO_0017711) (pancreatic colipase deficiency), [MONDO:0013235](http://purl.obolibrary.org/obo/MONDO_0013235) (pancreatic cancer, susceptibility to, 2), [MONDO:0012992](http://purl.obolibrary.org/obo/MONDO_0012992) (pancreatic insufficiency-anemia-hyperostosis syndrome), [MONDO:0009833](http://purl.obolibrary.org/obo/MONDO_0009833) (Shwachman-Diamond syndrome), [MONDO:0011739](http://purl.obolibrary.org/obo/MONDO_0011739) (pancreatic cancer, susceptibility to, 1), [MONDO:0017709](http://purl.obolibrary.org/obo/MONDO_0017709) (disorder of lipid absorption and transport), [MONDO:0013236](http://purl.obolibrary.org/obo/MONDO_0013236) (pancreatic cancer, susceptibility to, 3), [MONDO:0013700](http://purl.obolibrary.org/obo/MONDO_0013700) (pancreatic triacylglycerol lipase deficiency), [MONDO:0009061](http://purl.obolibrary.org/obo/MONDO_0009061) (cystic fibrosis), 

**Corr. equiv. classes:** [OMIM:606856](http://purl.obolibrary.org/obo/OMIM_606856), [Orphanet:586](http://www.orpha.net/ORDO/Orphanet_586), [OMIM:219700](http://purl.obolibrary.org/obo/OMIM_219700), [Orphanet:309031](http://www.orpha.net/ORDO/Orphanet_309031), [Orphanet:456312](http://www.orpha.net/ORDO/Orphanet_456312), [Orphanet:309111](http://www.orpha.net/ORDO/Orphanet_309111), [OMIM:260350](http://purl.obolibrary.org/obo/OMIM_260350), [Orphanet:199337](http://www.orpha.net/ORDO/Orphanet_199337), [OMIM:616263](http://purl.obolibrary.org/obo/OMIM_616263), [Orphanet:309028](http://www.orpha.net/ORDO/Orphanet_309028), [Orphanet:309108](http://www.orpha.net/ORDO/Orphanet_309108), [Orphanet:1333](http://www.orpha.net/ORDO/Orphanet_1333), [OMIM:614320](http://purl.obolibrary.org/obo/OMIM_614320), [OMIM:260400](http://purl.obolibrary.org/obo/OMIM_260400), [OMIM:614338](http://purl.obolibrary.org/obo/OMIM_614338), [OMIM:613348](http://purl.obolibrary.org/obo/OMIM_613348), [OMIM:613347](http://purl.obolibrary.org/obo/OMIM_613347), [Orphanet:811](http://www.orpha.net/ORDO/Orphanet_811), [OMIM:612714](http://purl.obolibrary.org/obo/OMIM_612714), [Orphanet:676](http://www.orpha.net/ORDO/Orphanet_676), [OMIM:167800](http://purl.obolibrary.org/obo/OMIM_167800), 

**Class expressions from DL-Learner:**

- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) 57.59%
- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) 57.59%
- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) 57.59%
- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0002242](http://purl.obolibrary.org/obo/HP_0002242) (Abnormality of the intestine) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 57.59%
- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) 57.59%
- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 55.11%
- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002024](http://purl.obolibrary.org/obo/HP_0002024) (Malabsorption) 53.02%
- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0002242](http://purl.obolibrary.org/obo/HP_0002242) (Abnormality of the intestine) 49.74%
- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 49.64%
- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0002024](http://purl.obolibrary.org/obo/HP_0002024) (Malabsorption) 49.64%
- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) 48.75%
- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) 48.75%
- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 48.25%
- [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) 47.02%
- [HP:0001392](http://purl.obolibrary.org/obo/HP_0001392) (Abnormality of the liver) and [HP:0001738](http://purl.obolibrary.org/obo/HP_0001738) (Exocrine pancreatic insufficiency) 45.91%


